Endocrinology

Your Article Summary

See Latest Articles

Denosumab update
Current Opinion in Rheumatology, 06/11/09

Lewiecki EM - Denosumab is a promising therapeutic agent for the management of postmenopausal osteoporosis and rheumatoid arthritis.

Related Articles

See all related articles

Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
The Journal of Urology, 11/16/09    Relevance Score: 87%

A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09    Relevance Score: 83%

Bone health and prostate cancer
Prostate Cancer & Prostatic Diseases, 11/13/09    Relevance Score: 77%

Today in Bone Metabolism...keeping you current

Receive free subspecialty "5-minute updates" via email

Fat Mass Exerts a Greater Effect on Cortical Bone Mass in Girls than Boys
Journal of Clinical Endocrinology and Metabolism, 12/17/09

Low Bone Mass and High Bone Turnover in Postmenopausal Human Immunodeficiency Virus-Infected Women
Journal of Clinical Endocrinology and Metabolism, 12/17/09

Epidemiology of hip fracture in Tucuman, Argentina
Osteoporosis International, 12/17/09

 See all of Bone Metabolism

Today in Pharmacology/kinetics...keeping you current

Receive free subspecialty "5-minute updates" via email

Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
Diabetes Technology & Therapeutics, 12/17/09

Metformin Reduces Arterial Stiffness and Improves Endothelial Function in Young Women with Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled, Crossover Trial
Journal of Clinical Endocrinology and Metabolism, 12/17/09

Difference in Insulin Usage Patterns with Pubertal Development in Children with Type 1 Diabetes During Transition from Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion (CSII) and Through the CSII Treatment
Diabetes Technology & Therapeutics, 12/17/09

 See all of Pharmacology/kinetics